Target intelligence / Profile preview

Reticulon 2 (RTN2)

Target
RTN2
Molecular classification
Membrane-associated protein, Endoplasmic reticulum protein, Reticulon family protein
01

Overview

Reticulon 2 is one of four mammalian reticulon proteins characterized by a conserved carboxy-terminal reticulon homology domain (RHD) with two unusually long hydrophobic membrane-associated domains flanking a central hydrophilic loop[1][2][3]. It localizes mainly to the endoplasmic reticulum, where it is thought to play a major role in shaping ER membrane curvature and maintaining ER structure[2]. RTN2 influences protein processing, secretion, and possibly vesicle transport between ER and other intracellular compartments[2][3]. Recent research demonstrates it is upregulated in gastric cancer, enhancing the migration, invasion, and metastatic behavior of cancer cells, likely through the activation of ERK signaling and promotion of epithelial-to-mesenchymal transition (EMT)[3]. Reticulons overall are also implicated in neurodegenerative disease pathways, highlighting their diverse cellular roles[1][3].

Other names
RTN2Neuroendocrine-specific protein
02

Mechanism of action

Mechanism for potential future drugs might include inhibition of ERK signaling or EMT, based on its role in cancer[3].

03

Biological functions

Endoplasmic reticulum structure and maintenanceMembrane morphogenesisProtein processing and secretionRegulation of cell migration and invasionPromotion of epithelial-to-mesenchymal transition (EMT) in cancer
04

Disease associations

Neurodegenerative disease (Alzheimer’s, amyotrophic lateral sclerosis)Cancer (especially gastric cancer metastasis)
05

Safety considerations

Its involvement in basic ER morphology and apoptosis suggests potential challenges in targeting without affecting normal cell function[1][2][3].
06

Biomarkers

RTN2 expression in tumors (prognostic indicator of poor outcome in gastric cancer)

Beyond the preview

Go deeper on Reticulon 2 (RTN2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reticulon 2 (RTN2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call